|
"whang peng j"的相关文件
显示项目 111-135 / 215 (共9页)
<< < 1 2 3 4 5 6 7 8 9 > >>
每页显示[10|25|50]项目
| 國家衛生研究院 |
2007-03 |
Effect of age on pulmonary metastases and immunotherapy in young and middle-aged mice
|
Chen, YM;Wang, PS;Liu, JM;Hsieh, YL;Tsai, CM;Perng, RP;Whang-Peng, J |
| 國家衛生研究院 |
2007-02-01 |
Monitoring and quantitative assessment of tumor burden using in vivo bioluminescence imaging
|
Chen, CC; Hwang, JJ; Ting, G; Tseng, YL; Wang, SJ; Whang-Peng, J |
| 國家衛生研究院 |
2007-02 |
Renal cell carcinoma with t(X;17)(p11.2;q25) in a 6-year-old Taiwanese boy
|
Chen, CK; Hsueh, C; Lai, JY; Hung, IJ; Whang-Peng, J; Wang, WP; Lai, HY; Chen, JR |
| 國家衛生研究院 |
2006-12-20 |
Therapeutic efficacy evaluation of 111in-VNB-liposome on human colorectal adenocarcinoma HT-29/luc mouse xenografts
|
Lee, WC; Hwang, JJ; Tseng, YL; Wang, HE; Chang, YF; Lu, YC; Ting, G; Whang-Peng, J; Wang, SJ |
| 國家衛生研究院 |
2006-12-20 |
Internal radiotherapy and dosimetric study for In-111/Lu-177-pegylated liposomes conjugates in tumor-bearing mice
|
Wang, HE; Yu, HM; Lu, YC; Heish, NN; Tseng, YL; Huang, KL; Chuang, KT; Chen, CH; Hwang, JJ; Lin, WJ; Wang, SJ; Ting, G; Whang-Peng, J; Deng, WP |
| 國家衛生研究院 |
2006-11 |
Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma
|
Shiah, HS; Chao, Y; Chen, LT; Yao, TJ; Huang, JD; Chang, JY; Chen, PJ; Chuang, TR; Chin, YH; Whang-Peng, J; Liu, TW |
| 國家衛生研究院 |
2006-10-01 |
Identification of alpha-enolase as an autoantigen in lung cancer: Its overexpression is associated with clinical outcomes
|
Chang, GC; Liu, KJ; Hsieh, CL; Hu, TS; Charoenfuprasert, S; Liu, HK; Luh, KT; Hsu, LH; Wu, CW; Ting, CC; Chen, CY; Chen, KC; Yang, TY; Chou, TY; Wang, WH; Whang-Peng, J; Shih, NY |
| 國家衛生研究院 |
2006-07 |
Salvage therapy for Chinese non-small cell lung cancer patients who failed previous chemotherapy
|
Chen, YM; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2006-06 |
A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy
|
Chen, YM; Perng, RP; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2006-05 |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang, HJ; Wang, CC; Cheng, AL; Hsu, C; Lu, YS; Chang, MC; Lin, JT; Wang, HP; Shiah, HS; Liu, TW; Chang, JY; Whang-Peng, J; Chen, LT |
| 國家衛生研究院 |
2006-04 |
Nodal dissection for patients with gastric cancer: a randomised controlled trial
|
Wu, CW; Hsiung, CA; Lo, SS; Hsieh, MC; Chen, JH; Li, AFY; Lui, WY; Whang-Peng, J |
| 國家衛生研究院 |
2006-04 |
A randomized trial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy
|
Chen, YM; Shih, JF; Perng, RP; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2006-04 |
Erlotinib completely reverses topotecan-resistance in multidrug resistant cancer cells overexpressing breast cancer resistant protein 1
|
Yang, CH;Yang, CS;Huang, CJ;Cheng, AL;Whang-Peng, J;Yang, PC |
| 國家衛生研究院 |
2006-04 |
Topoisomerase 2 alpha plays a pivotal role in the tumor biology of advanced thymic neoplasia
|
Liu, JM;Hwang, BS;Wang, LS;Huang, MH;Yen, SH;Li, A;Tiu, CM;Whang-Peng, J |
| 國家衛生研究院 |
2006-03 |
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer
|
Shiah, HS; Cheng, AL; Hsu, C; Hsu, CH; Liu, TW; Chang, JY; Jan, CM; Chao, Y; Yu, WL; Chuang, TR; Whang-Peng, J; Chen, LT |
| 國家衛生研究院 |
2006-02 |
A phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly
|
Chen, YM; Perng, RP; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2006-01 |
Complications following D3 gastrectomy: Post hoc analysis of a randomized trial
|
Wu, CW; Chang, IS; Lo, SS; Hsieh, MC; Chen, JH; Lui, WY; Whang-Peng, J |
| 國家衛生研究院 |
2005-12 |
Pulmonary embolism after transcatheter arterial chemoembolization
|
Shiah, HS; Liu, TW; Chen, LT; Chang, JY; Liu, JM; Chuang, TR; Lee, WS; Whang-Peng, J |
| 國家衛生研究院 |
2005-09-21 |
Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma
|
Chen, LT; Lin, JT; Tai, JJ; Chen, GH; Yeh, HZ; Yang, SS; Wang, HP; Kuo, SH; Sheu, BS; Jan, CM; Wang, WM; Wang, TE; Wu, CW; Chen, CL; Su, IJ; Whang-Peng, J; Cheng, AL |
| 國家衛生研究院 |
2005-09-14 |
Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients
|
Su, WP;Wen, CC;Hsiung, CA;Su, IJ;Cheng, AL;Chang, MC;Tsao, CJ;Kao, WY;Uen, WC;Hsu, CH;Lu, YS;Tien, HF;Chao, TY;Chen, LT;Whang-Peng, J;Chen, PJ |
| 國家衛生研究院 |
2005-09 |
Long-term complete remission of metastatic gastric cancer after weekly docetaxel, 24 h infusion of high-dose 5-FU/leucovorin and cisplatin
|
Chan, CH; Liu, TW; Chen, LT; Chang, JY; Whang-Peng, J |
| 國家衛生研究院 |
2005-08-01 |
Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein
|
Yang, CH; Huang, CJ; Yang, CS; Chu, YC; Cheng, AL; Whang-Peng, J; Yang, PC |
| 國家衛生研究院 |
2005-08-01 |
alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma
|
Chen, LT; Liu, TW; Chao, Y; Shiah, HS; Chang, JY; Juang, SH; Chen, SC; Chuang, TR; Chin, YH; Whang-Peng, J |
| 中國醫藥大學 |
2005-08 |
α-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma
|
(Chen. L.-T.*)*; (Liu, T.-W.); (Chao, Y); (Shiah, H.-S); (Chang, J.-Y.,); 莊聲宏(Shin-Hun Juang); (Chen, S.-C.); (Chuang, T.-R); (Chin, Y.-H.); (Whang-Peng, J.) |
| 國家衛生研究院 |
2005-07 |
erb-b2 amplification by fluorescence in situ hybridization in breast cancer specimens read as 2+in immunohistochemical analysis
|
Lan, C; Liu, JM; Liu, TW; Hsu, DH; Liang, SC; Chen, JR; Whang-Peng, J |
显示项目 111-135 / 215 (共9页)
<< < 1 2 3 4 5 6 7 8 9 > >>
每页显示[10|25|50]项目
|
